Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: A comparison with 18F-FDG and 18F-FLT

Journal of Nuclear Medicine

Volumn 49, Issue 1, 2008, Pages 135-141

  Zhao, Songji ^a   Kuge, Yuji ^a,b   Kohanawa, Masashi ^a   Takahashi, Toshiyuki ^c   Zhao, Yan ^a   Yi, Min ^a   Kanegae, Kakuko ^a   Seki, Koh Ichi ^d   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Hokkaido Gastroenterology Hospital   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

11C methionine; Granuloma; Inflammation; Rat; Tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROTHYMIDINE F 18; GLUCOSE; METHIONINE C 14; RADIOPHARMACEUTICAL AGENT; TURPENTINE; UNCLASSIFIED DRUG; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; CARBON; DIAGNOSTIC AGENT; METHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; GRANULOMA; HISTOCHEMISTRY; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; INFLAMMATION; LIVER TUMOR; MALE; MICROBIOLOGY; MYCOBACTERIUM BOVIS; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIAGNOSIS, DIFFERENTIAL; DIDEOXYNUCLEOSIDES; FLUORODEOXYGLUCOSE F18; GRANULOMA; INFLAMMATION; LIVER NEOPLASMS; MALE; METHIONINE; MYCOBACTERIUM BOVIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; TURPENTINE;

EID: 37648999876     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.044578     Document Type: Article

References (29)

1. Delbeke D, Rose DM, Chapman WC, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med. 1999;40:1784-1791.
2. 18F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med. 2002;43:510-518.
3. Brudin LH, Valind S, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med. 1994;21:297-305.
4. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35:1647-1649.
5. 18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer. Jpn J Clin Oncol. 2005;35:271-273.
6. Lorenzen J, de Wit M, Buchert R, Igel B, Bohuslavizki KH. Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy. Nuklearmedizin. 1999;38:333-336.
7. Conessa C, Hervé S, Foehrenbach H, Poncet JL. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol. 2004;113:628-635.
8. 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695-700.
9. van Waarde A. Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med. 2006;47:150-154.
10. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.
11. Sherley JL, Kelly TJ. Regulation of human thymidine kinase during the cell cycle. J Biol Chem. 1988;263:8350-8358.
12. Jacobs AH, Dittmar C, Winkeler A, Garlip G, Heiss WD. Molecular imaging of gliomas. Mol Imaging. 2002;1:309-335.
13. Tsuyuguchi N, Sunada I, Ohata K, et al. Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med. 2003;17:47-51.
14. Kubota K, Kubota R, Yamada S, Tada M. Effects of radiotherapy on the cellular uptake of carbon-14 labeled L-methionine in tumor tissue. Nucl Med Biol. 1995;22:193-198.
15. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med. 1995;36:484-492.
16. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med. 1997;38:280-287.
17. Zhao S, Kuge Y, Kohanawa M, et al. Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors. Eur J Med Mol Imaging. September 1, 2007 [Epub ahead of print].
18. Zhao S, Kuge Y, Tsukamoto E, et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med. 2001;28:730-735.
19. 18F-FDG, and histologic evaluation. J Nucl Med. 2005;46:794-799.
20. Yamada Y, Uchida Y, Tatsumi K, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med. 1998;39:1160-1166.
21. 11C]methionine. Jpn J Cancer Res. 1989;80:778-782.
22. 18F]fluoro-2-deoxy-D- glucose as a potential in vitro agent for labeling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B. 1992;19:183-190.
23. Borregaard N. Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest. 1982;70:550-557.
24. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
25. Saga T, Kawashima H, Araki N, et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med. 2006;31:774-780.
26. 18F-fluorodeoxyglucose-positron emission tomography. Chest. 2006;129:393-401.
27. Drent M, du Bois RM, Poletti V. Recent advances in the diagnosis and management of nonspecific interstitial pneumonia. Curr Opin Pulm Med. 2003;9:411-417.
28. Inoue T, Kim EE, Wong FC, et al. Comparison of fluorine-18- fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. J Nucl Med. 1996;37:1472-1476.
29. Kubota K, Ishiwata K, Kubota R, et al. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine. J Nucl Med. 1996;37:320-325.